Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Cell Metabolism|March 10, 2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic SubjectsSaswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.Diabetes|November 24, 2011
SirT1 regulates adipose tissue inflammationMatthew P Gillum, Maya E Kotas, Derek M Erion, et al.Cell Metabolism|March 4, 2009
The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistanceYoshio Nagai, Shin Yonemitsu, Derek M Erion, et al.Diabetes|November 14, 2013
The mammalian INDY homolog is induced by CREB in a rat model of type 2 diabetesFrank Neuschäfer-Rube, Stefanie Lieske, Manuela Kuna, et al.Nature|May 23, 2014
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenaseAnila K Madiraju, Derek M Erion, Yasmeen Rahimi, et al.JHEP Reports : Innovation in Hepatology|January 25, 2021
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesisEmma L Shepherd, Raquel Saborano, Ellie Northall, et al.Hepatology (Baltimore, Md.)|November 24, 2012
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsNaoki Kumashiro, Toru Yoshimura, Jennifer L Cantley, et al.Cell Metabolism|December 1, 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding proteinDerek M Erion, Irena D Ignatova, Shin Yonemitsu, et al.Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.Molecular Metabolism|March 5, 2021
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunctionJemy A Gutierrez, Wei Liu, Sylvie Perez, et al.Pageof 5